|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Young-Woo Kim Han-Kwang Yang Hyun Cheol Chung Young-Kyu Park Kyung Hee Lee Keun-Wook Lee Yong Ho Kim Sang-Ik Noh Jae Yong Cho Young Jae Mok Yeul Hong Kim Jiafu Ji Ta-Sen Yeh Peter Button Florin Sirzén Sung Hoon Noh | 2012 | The Lancet2012，，9813： | 10 |
| 2 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Young-Woo Kim Han-Kwang Yang Hyun Cheol Chung Young-Kyu Park Kyung Hee Lee Keun-Wook Lee Yong Ho Kim Sang-Ik Noh Jae Yong Cho Young Jae Mok Yeul Hong Kim Jiafu Ji Ta-Sen Yeh Peter Button Florin Sirzén Sung Hoon Noh | 2012 | The Lancet . 2012 (9813)2012，，9813： | 7 |
| 3 | Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study显示文摘 | Hedy L Kindler Tatsuya Ioka Dirk J Richel Jaafar Bennouna Richard Létourneau Takuji Okusaka Akihiro Funakoshi Junji Furuse Young Suk Park Shinichi Ohkawa Gregory M Springett Harpreet S Wasan Peter C Trask Paul Bycott Alejandro D Ricart Sinil Kim Eric Van | 2011 | Lancet Oncology2011，，3： | 4 |
| 4 | Chemical and biological transformations for detoxification of trichothecene mycotoxins in human and animal food chains: a review显示文摘 | Jianwei He Ting Zhou J. Christopher Young Greg J. Boland Peter M. Scott | 2009 | Trends in Food Science & Technology2009，，2： | 3 |
| 5 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Young-Woo Kim Han-Kwang Yang Hyun Cheol Chung Young-Kyu Park Kyung Hee Lee Keun-Wook Lee Yong Ho Kim Sang-Ik Noh Jae Yong Cho Young Jae Mok Yeul Hong Kim Jiafu Ji Ta-Sen Yeh Peter Button Florin Sirzén Sung Hoon Noh | 2012 | The Lancet2012，，9813： | 3 |
| 6 | Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)显示文摘 | Francesca Tentori Margaret J. Blayney Justin M. Albert Brenda W. Gillespie Peter G. Kerr Jürgen Bommer Eric W. Young Tadao Akizawa Takashi Akiba Ronald L. Pisoni Bruce M. Robinson Friedrich K. Port | 2008 | American Journal of Kidney Diseases2008，，3： | 3 |
| 7 | Indications and surgical options for small bowel, large bowel and perianal Crohn's disease显示文摘Despite advancements in medical therapy of Crohn's disease(CD), majority of patients with CD will eventually require surgical intervention, with at least a third of patients requiring multiple surgeries. It is important to understand the role and timing of surgery, with the goals of therapy to reduce the need for surgery without increasing the odds of emergency surgery and its associated morbidity, as well as to limit surgical recurrence and avoid intestinal failure. The profile of CD patients requiring surgical intervention has changed over the decades with improvements in medical therapy with immunomodulators and biological agents. The most common indication for surgery is obstruction from stricturing disease, followed by abscesses and fistulae. The risk of gastrointestinal bleeding in CD is high but the likelihood of needing surgery for bleeding is low. Most major gastrointestinal bleeding episodes resolve spontaneously, albeit the risk of re-bleeding is high. The risk of colorectal cancer associated with CD is low. While current surgical guidelines recommend a total proctocolectomy for colorectal cancer associated with CD, subtotal colectomy or segmental colectomy with endoscopic surveillance may be a reasonable option. Approximately 20%-40% of CD patients will need perianal surgery during their lifetime. This review assesses the practice parameters and guidelines in the surgical management of CD, with a focus on the indications for surgery in CD(and when not to operate), and a critical evaluation of the timing and surgical options available to improve outcomes and reduce recurrence rates. | James WT Toh Peter Stewart Matthew JFX Rickard Rupert Leong Nelson Wang Christopher J Young | 2016 | World Journal of Gastroenterology2016，22，40： | 2 |
| 8 | Diagnosis and Initial Management of Blunt Pancreatic Trauma: Guidelines From a Multiinstitutional Review显示文摘 | Edward L. Bradley Peter R. Young Michael C. Chang James E. Allen Christopher C. Baker Wayne Meredith Larry Reed Michael Thomason | 1998 | Annals of Surgery1998，，6： | 2 |
| 9 | The synthetic rock mass approach for jointed rock mass modelling显示文摘 | Diego Mas Ivars Matthew E. Pierce Caroline Darcel Juan Reyes-Montes David O. Potyondy R. Paul Young Peter A. Cundall | 2010 | International Journal of Rock Mechanics and Mining Sciences2010，，2： | 2 |
| 10 | GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications显示文摘 | Peter Bytzer Nicholas J Talley Johann Hammer Lisa J Young Michael P Jones Michael Horowitz | 2002 | The American Journal of Gastroenterology2002，，3： | 2 |
| 11 | Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors显示文摘 | Wan Zhihong Zhi Ning Wong Susan Keyvanfar Keyvan Liu Delong Raghavachari Nalini Munson Peter J Su Su Malide Daniela Kajigaya Sachiko Young Neal S | 2010 | Journal of Clinical Investigation2010，，10： | 2 |
| 12 | Sonication of proteins causes formation of aggregates that resemble amyloid显示文摘 | Peter B.Stathopulos Guenter A.Scholz Young‐MiHwang Jessica A.O.Rumfeldt James R.Lepock Elizabeth M.Meiering | 2008 | Protein Science2008，，11： | 1 |
| 13 | Carbonyl sulfide hydrolysis using alumina catalyst显示文摘 | WILLIAMS B Peter YOUNG Nicola C JOHN West | 1999 | Catalysis Today1999，49，： | 1 |
| 14 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Young-Woo Kim Han-Kwang Yang Hyun Cheol Chung Young-Kyu Park Kyung Hee Lee Keun-Wook Lee Yong Ho Kim Sang-Ik Noh Jae Yong Cho Young Jae Mok Yeul Hong Kim Jiafu Ji Ta-Sen Yeh Peter Button Florin Sirzén Sung Hoon Noh | 2012 | 2012 (9813)2012，，9813： | 1 |
| 15 | Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits显示文摘 | Jens U. Marquardt Daekwan Seo Jesper B. Andersen Matthew C. Gillen Myoung Soo Kim Elizabeth A. Conner Peter R. Galle Valentina M. Factor Young Nyun Park Snorri S. Thorgeirsson | 2014 | Journal of Hepatology2014，，2： | 1 |
| 16 | Electron spin resonance spectroscopy:exercise,and oxidative stress:an ascorbic acid intervention study显示文摘 | Ashton T Young IS Peters JR | 1999 | J Appl Physiol1999，87，6： | 1 |
| 17 | Investigation of multipotent postnatal stem cells from human periodontal ligament显示文摘 | Byoung-Moo Seo Masako Miura Stan Gronthos Peter Mark Bartold Sara Batouli Jaime Brahim Marian Young Pamela Gehron Robey Cun Yu Wang Songtao Shi | 2004 | The Lancet2004，，9429： | 1 |
| 18 | 5‐cm‐Precision aircraft ocean altimetry using GPS reflections显示文摘 | Stephen T. Lowe Cinzia Zuffada Yi Chao Peter Kroger Larry E. Young John L. LaBrecque | 2002 | Geophys. Res. Lett2002，，10： | 1 |
| 19 | Identification of non-linear stochastic systems by state dependent parameter estimation显示文摘 | Peter C. Young Paul McKenna John Bruun | 2001 | International Journal of Control2001，，18： | 1 |
| 20 | Lipins, lipinopathies, and the modulation of cellular lipid storage and signaling显示文摘 | Lauren S. Csaki Jennifer R. Dwyer Loren G. Fong Peter Tontonoz Stephen G. Young Karen Reue | 2013 | Progress in Lipid Research2013，，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员